Sheryl Zelenitsky
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria 26
- Pharmacology top 0.2%
- Antibiotics Pharmacokinetics and Efficacy 45
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 16
- Infectious Diseases top 1%
- Antimicrobial Resistance in Staphylococcus 19
- Antifungal resistance and susceptibility 8
-
- Pneumonia and Respiratory Infections 19
-
- Central Venous Catheters and Hemodialysis 11
-
- Dialysis and Renal Disease Management 8
- Co-authors
- Robert E. ArianoGeorge G. ZhanelJames A. KarlowskyFrank SchweizerPhilippe Lagacé‐WiensHeather J. AdamDaryl J. HobanAlfred S. Gin
- Journals
- Drugs (13 papers)Journal of Antimicrobial Chemotherapy (13 papers)Antimicrobial Agents and Chemotherapy (10 papers)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
Sheryl Zelenitsky
78 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Molecular Medicine 2.0k
- Applied Microbiology and Biotechnology 738
- Pharmacology 2.1k
- Clinical Biochemistry 555
- Infectious Diseases 1.0k
Countries citing papers authored by Sheryl Zelenitsky
This map shows the geographic impact of Sheryl Zelenitsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheryl Zelenitsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheryl Zelenitsky more than expected).
Fields of papers citing papers by Sheryl Zelenitsky
This network shows the impact of papers produced by Sheryl Zelenitsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheryl Zelenitsky. The network helps show where Sheryl Zelenitsky may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sheryl Zelenitsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 4 | |
| 3 | 2020 | 37 | |
| 4 | Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacillibreakdown → | 2019 | 311 |
| 5 | 2016 | 214 | |
| 6 | 2015 | 138 | |
| 7 | 2015 | 135 | |
| 8 | 2014 | 33 | |
| 9 | 2012 | 165 | |
| 10 | 2011 | 3 | |
| 11 | 2010 | 84 | |
| 12 | 2010 | 83 | |
| 13 | 2010 | 262 | |
| 14 | 2009 | 118 | |
| 15 | 2008 | 7 | |
| 16 | 2005 | 68 | |
| 17 | 2004 | 3 | |
| 18 | 2000 | 31 | |
| 19 | 1997 | 26 | |
| 20 | 1996 | 2 |
About Sheryl Zelenitsky
Sheryl Zelenitsky is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Pharmacology, Clinical Biochemistry and Infectious Diseases, having authored 80 papers that have together received 4.3k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (45 papers), Antibiotic Resistance in Bacteria (26 papers), Antimicrobial Resistance in Staphylococcus (19 papers), Pneumonia and Respiratory Infections (19 papers), Bacterial Identification and Susceptibility Testing (16 papers), Central Venous Catheters and Hemodialysis (11 papers), Dialysis and Renal Disease Management (8 papers) and Antifungal resistance and susceptibility (8 papers). The work is most often cited by research in Molecular Medicine (2.0k citations), Applied Microbiology and Biotechnology (738 citations), Pharmacology (2.1k citations), Clinical Biochemistry (555 citations) and Infectious Diseases (1.0k citations). Sheryl Zelenitsky has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Robert E. Ariano, George G. Zhanel, James A. Karlowsky, Frank Schweizer, Philippe Lagacé‐Wiens, Heather J. Adam, Daryl J. Hoban, Alfred S. Gin, Joseph P. Lynch and Ethan Rubinstein. Their work appears in journals such as Drugs, Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, Annals of Pharmacotherapy and Diagnostic Microbiology and Infectious Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.